cas 2306272-72-8|| where to buy 2-{4-[(benzyloxy)carbonyl]piperazin-1-yl}acetic acid hydrochloride

Nom du produit:2-{4-[(benzyloxy)carbonyl]piperazin-1-yl}acetic acid hydrochloride

IUPAC Name:2-{4-[(benzyloxy)carbonyl]piperazin-1-yl}acetic acid hydrochloride

: CAS：2306272-72-8; Formule moléculaire：C14H19ClN2O4; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM391044-500mg	in stock	ƦƎȺ
CM391044-1g	in stock	ǊƎǊ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2306272-72-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2306272-72-8; Formule moléculaire:C14H19ClN2O4; Point de fusion:-; Code SMILES:Cl.OC(=O)CN1CCN(CC1)C(=O)OCC1=CC=CC=C1; Densité:

: Numéro de catalogue:CM391044; Poids moléculaire:314.77; Point d'ébullition:; N° Mdl:; Stockage:

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Lorundrostat; Mineralys Therapeutics announced that the first subject has been dosed in the Launch-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN) or resistant hypertension (rHTN), when used as an add-on therapy to prescribed background treatment. Lorundrostat is a proprietary, orally administered, highly selective aldosterone synthase inhibitor being developed for the treatment of uncontrolled and resistant hypertension and CKD. Lorundrostat was designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for its production.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.